Leukemia Virus Type I 1 Infection Frequently Goes Undetected in Contemporary US Blood Donors

Serologic screening for human T-cell leukemia virus type I (HTLV-I) infection was begun in US blood banks with the licensure of enzyme-linked immunosorbent assays (ELISA) in December 1988. We examined the donation histories of the first 60 Western blot (WB)-confirmed HTLV-1/11 positive donors to one blood center and found 8 had made 16 previous donations that scored negative on the screening ELISA. All 16 donations had ELISA absorbance below the cutoff for a positive assay, but still well above that of the average donation (1 7.6% f 5.7% of the cutoff). In a more extensive study, 1 7 donations from a total of 61,752 at six

[1]  B. Hjelle,et al.  Chronic neurodegenerative disease associated with HTLV-II infection , 1992, The Lancet.

[2]  M. Ascher,et al.  Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II , 1992, Journal of clinical microbiology.

[3]  W. Blattner,et al.  Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. , 1992, The Journal of infectious diseases.

[4]  E. Fontham,et al.  Sensitivity of HTLV-I antibody assays for HTLV-II , 1991, The Lancet.

[5]  B. Hjelle Human T-cell leukemia/lymphoma viruses. Life cycle, pathogenicity, epidemiology, and diagnosis. , 1991, Archives of pathology & laboratory medicine.

[6]  C. Fang,et al.  Human T-cell lymphotropic virus type I and II in transfusion medicine. , 1991, Transfusion medicine reviews.

[7]  C. Key,et al.  Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. , 1991, The Journal of infectious diseases.

[8]  L. Resnick,et al.  Tropical spastic paraparesis‐like illness occurring in a patient dually infected with HIV‐1 and HTLV‐II , 1991, Neurology.

[9]  W. Blattner,et al.  Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide , 1990, Journal of clinical microbiology.

[10]  R. Wilks,et al.  Distinguishing between HTLV-I and HTLV-II by western blot , 1990, The Lancet.

[11]  W. Blattner,et al.  Licensure of screening tests for antibody to human T-lymphotropic virus type I. , 1988, MMWR. Morbidity and mortality weekly report.